{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:10:16Z","timestamp":1770725416980,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.053","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T12:37:50Z","timestamp":1606221470000},"page":"343-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0623-066X","authenticated-orcid":false,"given":"Taito","family":"Kitano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirosato","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2020.11.053_b0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(08)70152-X","article-title":"Haemophilus influenzae type b conjugate vaccine use and effectiveness","volume":"8","author":"Morris","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2020.11.053_b0010","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1016\/j.vaccine.2018.08.029","article-title":"A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan","volume":"36","author":"Suga","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.053_b0015","article-title":"Routine vaccination during covid-19 pandemic response","volume":"369","author":"Saxena","year":"2020","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.vaccine.2020.11.053_b0020","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.19.2000848","article-title":"Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020","volume":"25","author":"McDonald","year":"2020","journal-title":"Euro Surveill"},{"issue":"20","key":"10.1016\/j.vaccine.2020.11.053_b0025","doi-asserted-by":"crossref","first-page":"630","DOI":"10.15585\/mmwr.mm6920e1","article-title":"Decline in child vaccination coverage during the COVID-19 pandemic \u2014 Michigan Care Improvement Registry, May 2016\u2013May 2020","volume":"69","author":"Bramer","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.11.053_b0030","unstructured":"Know VPD! Protect Our Children. Release: decreased childhood vaccination rate due to COVID-19 outbreak; 2020 [Japanese] https:\/\/www.know-vpd.jp\/news\/20741.php [accessed on June 28, 2020]."},{"issue":"1","key":"10.1016\/j.vaccine.2020.11.053_b0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3201\/eid1801.110336","article-title":"Modeling insights into Haemophilus influenzae Type b disease, transmission, and vaccine programs","volume":"18","author":"Jackson","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.11.053_b0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10156-013-0641-6","article-title":"Vaccine chronicle in Japan","volume":"19","author":"Nakayama","year":"2013","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.vaccine.2020.11.053_b0045","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/jpids\/piz005","article-title":"The 112-year odyssey of pertussis and pertussis vaccines\u2014mistakes made and implications for the future","volume":"8","author":"Cherry","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2020.11.053_b0050","unstructured":"National Institute of Infectious Diseases. Japanese Encephalitis Vaccine Supply System. Infectious Agents Surveillance Report IASR 2017;38:165\u20136 [Japanese] https:\/\/www.niid.go.jp\/niid\/ja\/typhi-m\/iasr-reference\/2410-related-articles\/related-articles-450\/7470-450r10.html [accessed November 12, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0055","first-page":"1","article-title":"Close the gap for routine mumps vaccination in Japan","volume":"12","author":"Kitano","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.11.053_b0060","unstructured":"Statistics Bureau, Ministry of internal affairs and communications. Statistics Japan, Statistical Yearbook\u2019; 2020. Tokyo http:\/\/www.stat.go.jp\/english\/index.htm [accessed July 22, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0065","unstructured":"Cabinet Office, Government of Japan. The state of population aging. Tokyo; 2017. http:\/\/www8.cao.go.jp\/kourei\/whitepaper\/w-2016\/html\/zenbun\/s1_1_1.html [accessed July 22, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0070","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/315870","article-title":"Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration","volume":"182","author":"Fernandez","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.053_b0075","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(96)06392-1","article-title":"Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster","volume":"349","author":"Booy","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.11.053_b0080","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1001\/jama.284.18.2334","article-title":"Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom","volume":"284","author":"Heath","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.11.053_b0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jiac.2019.11.012","article-title":"Immunogenicity and safety of a DTaP-IPV\/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan","volume":"26","author":"Nakayama","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2020.11.053_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/infdis\/136.2.222","article-title":"Pharyngeal colonization with Haemophilus influenzae type b: a longitudinal study of families with a child with meningitis or epiglottitis due to H. influenzae type b","volume":"136","author":"Michaels","year":"1977","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.053_b0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10156-011-0323-1","article-title":"Genotyping of Haemophilus influenzae type b in pre-vaccination era","volume":"18","author":"Otsuka","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2020.11.053_b0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1442-200X.1997.tb03637.x","article-title":"Nasopharyngeal colonization with Haemophilus influenzae type b among infants and children in Japan","volume":"39","author":"Kuroki","year":"1997","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.vaccine.2020.11.053_b0105","unstructured":"National Institute of Infectious Diseases. Infectious disease surveillance annual report. http:\/\/www.nih.go.jp\/niid\/ja\/allarticles\/surveillance\/2085-idwr\/ydata\/6555-ydata2015.html [accessed July 28, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0110","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs). https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html [accessed August 1, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0115","unstructured":"ECDC. European Centre for Disease Prevention and Control. Annual Epidemiological Reports on invasive Haemophilus influenzae disease. https:\/\/www.ecdc.europa.eu\/en\/invasive-haemophilus-influenzae-disease\/surveillance-and-disease-data\/aer [accessed August 1, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0120","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/14760584.2017.1383157","article-title":"A review of Haemophilus influenzae disease in Europe from 2000\u20132014: challenges, successes and the contribution of hexavalent combination vaccines","volume":"16","author":"Wang","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.11.053_b0125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/INF.0b013e31812f4f5b","article-title":"Invasive infections caused by Haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996\u20132001","volume":"26","author":"McConnell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.11.053_b0130","unstructured":"Ministry of Health, Labour and Welfare of Japan. The Subcommittee on Vaccination and Vaccines of the Health Sciences Council. Fact Sheet. Haemophilus influenzae type b vaccine working group [Japanese] https:\/\/www.mhlw.go.jp\/stf2\/shingi2\/2r9852000000bx23-att\/2r9852000000bxfi.pdf [accessed July 24, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0135","unstructured":"Ministry of Health, Labour and Welfare of Japan. The number of vaccinated persons in routine vaccination [Japanese] https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html [accessed August 1, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0140","unstructured":"Shibayama K, Wakui T, Suzuki S. Effectiveness of Haemophilus Influenzae type b vaccine based on Japan Nosocomial Infections Surveillance Data. Infectious Agents Surveillance Report. 2013;34:197\u20139 [Japanese]. https:\/\/www.niid.go.jp\/niid\/ja\/iasr-sp\/2253-related-articles\/related-articles-401\/3711-dj4019.html [accessed on August 1, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0145","first-page":"1","article-title":"The estimated impact of decreased childhood vaccination due to COVID-19 using a dynamic transmission model of mumps in Japan","author":"Kitano","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.11.053_b0150","unstructured":"Ministry of Health, Labour and Welfare of Japan. Coverage rate of measles-rubella vaccine by prefecture [Japanese] https:\/\/www.mhlw.go.jp\/bunya\/kenkou\/kekkaku-kansenshou21\/dl\/201014-02.pdf [accessed November 13, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0155","unstructured":"National Institute of Infectious Diseases. Infectious disease weekly report. https:\/\/www.niid.go.jp\/niid\/ja\/idwr.html [accessed November 13, 2020]."},{"issue":"Nov","key":"10.1016\/j.vaccine.2020.11.053_b0160","first-page":"ciaa1682","article-title":"Impact of non-pharmaceutical interventions on the incidence of respiratory infections during the COVID-19 outbreak in Korea: a nationwide surveillance study","author":"Huh","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.053_b0165","doi-asserted-by":"crossref","DOI":"10.2196\/19368","article-title":"Mathematical modelling to assess the impact of lockdown on COVID-19 transmission in India: model development and validation","volume":"6","author":"Ambikapathy","year":"2020","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2020.11.053_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.scs.2020.102390","article-title":"The efficacy of social distance and ventilation effectiveness in preventing COVID-19 transmission","volume":"62","author":"Sun","year":"2020","journal-title":"Sustain Cities Soc"},{"key":"10.1016\/j.vaccine.2020.11.053_b0175","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12916-020-01705-8","article-title":"Simulating the effect of school closure during COVID-19 outbreaks in Ontario","volume":"18","author":"Abdollahi","year":"2020","journal-title":"Canada BMC Med"},{"key":"10.1016\/j.vaccine.2020.11.053_b0180","unstructured":"Ministry of Health, Labour and Welfare of Japan. Basic Policies for Novel Coronavirus Disease Control by the Government of Japan (summary), Revised on May 25, 2020. https:\/\/www.mhlw.go.jp\/content\/10900000\/000634753.pdf [accessed July 28, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40121-014-0053-7","article-title":"Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal vaccine in Japanese children","volume":"4","author":"Shiragami","year":"2014","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2020.11.053_b0190","first-page":"2206","article-title":"Burden of illness of bacterial meningitis and bacteremia caused by Streptococcus pneumonia in children","volume":"61","author":"Iwata","year":"2008","journal-title":"Jpn J Pediatr"},{"key":"10.1016\/j.vaccine.2020.11.053_b0195","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.vaccine.2009.01.127","article-title":"Invasive pneumococcal disease in the Netherlands: syndromes, outcome and potential vaccine benefits","volume":"27","author":"Jansen","year":"2009","journal-title":"Vaccine"},{"issue":"340","key":"10.1016\/j.vaccine.2020.11.053_b0200","article-title":"Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines","volume":"2","author":"Rozenbaum","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.11.053_b0205","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0895-4356(02)00448-1","article-title":"The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison","volume":"55","author":"Oostenbrink","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2020.11.053_b0210","unstructured":"Ministry of Health, Labour and Welfare of Japan. Health Japan 21 (the second term) Analysis and Assessment Project. https:\/\/www.mhlw.go.jp\/stf\/shingi2\/0000196943.html [accessed July 28, 2020]."},{"key":"10.1016\/j.vaccine.2020.11.053_b0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10198-010-0292-9","article-title":"Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis","volume":"13","author":"Schad","year":"2012","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.vaccine.2020.11.053_b0220","first-page":"1","article-title":"Dynamic transmission model of routine mumps vaccination in Japan","volume":"147","author":"Kitano","year":"2018","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2020.11.053_b0225","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40273-018-0672-z","article-title":"Discounting in economic evaluations","volume":"36","author":"Attema","year":"2018","journal-title":"Pharmacoeconomics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20315061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:50:40Z","timestamp":1759402240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20315061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20315061"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}